2018 Pharma Choice Unbranded Bronze Winner NAVICOR and Celgene Corporation

NAVICOR

Celgene Corporation

Celgene “Chemosaurus”

Chemotherapy, a backbone of indolent non-Hodgkin’s lymphoma therapy for more than 50 years, has not evolved to match recent improved understanding of iNHL. Celgene is focused on therapies that allow cancer patients to thrive during treatment, virtually rendering chemotherapy extinct.

Agency Team:

Managing Director, Executive Creative Director: Marvin J. Bowe, III
VP, Creative Director: James A. Griffith II
ACD, Copy: Tom Ferrara
ACD, Art: Ana Ferreira
Sr. Art Director: John Catania
Sr. Art Director: Monica Ibarra
Design & Fabrication Firm: Creative Machines
CGI Artist: Taylor James

Ads

You May Also Like

2021 Pharma Choice Variety (Chat Tool) Silver Winner Intouch Group, Regeneron Pharmaceuticals, and Sanofi Genzyme

Intouch Group, Regeneron Pharmaceuticals, and Sanofi Genzyme DUPIXENT’s Industry-Leading Patient Chat Tool The DUPIXENT ...

PM360 2019 Innovative Company HealthSTAR Communications

HealthSTAR Communications Patrick Purcell, SVP Strategic Solutions ppurcell@healthstarcom.com For over two decades HealthSTAR Communications ...

PM360’s Investor Portfolio: Steven Krein

PM360 introduces you to the people who invest in and help startups succeed. In ...